Among these targets are the vascular endothelial growth factor receptor-2 (VEGFR-2) which is one of the key intermediates in tumour angiogenesis6, and the anti-apoptotic and pro-apoptotic proteins that regulate the cellular apoptosis.7–9. Here, KDR is linked to neoplasm.